43 results found.

Osteoporosis Clinical Trial using odanacatib; placebo to odanacatib

Merck Sharp & Dohme Corp. - Recruiting 60 years or older.
- A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Overall Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate.
odanacatib; placebo to odanacatib

Postmenopausal Osteoporosis Clinical Trial using AMG 785; Teriparatide (TPTD)

Amgen - Recruiting 60 years to 90 years.
- An Open-label, Randomized, Teriparatide-controlled Study to Evaluate the Effect of Treatment With AMG 785 in Postmenopausal Women With Osteoporosis Previously Treated With Bisphosphonate Therapy.
AMG 785; Teriparatide (TPTD)

Postmenopausal Women With Osteoporosis Clinical Trial using Romosozumab; Alendronate

Amgen - Recruiting 55 years to 90 years.
- A Multicenter, International, Randomized, Double-blind, Alendronate-controlled Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis.
Romosozumab; Alendronate

Rheumatoid Arthritis Clinical Trial using GLPG0634; Placebo

Galapagos NV - Recruiting 18 years or older.
- Randomized, Double-blind, Placebo-controlled, Multicenter, Phase IIb Dose Finding Study of GLPG0634 Administered for 24 Weeks in Combination With Methotrexate to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Alone.
GLPG0634; Placebo

Involutional Osteoporosis Clinical Trial using NE-58095; NE-58095NF

Takeda - Recruiting 50 years or older.
- A Phase II/III Multicenter, Randomized, Double-blind, Parallel Group Comparative Study to Evaluate the Efficacy and Safety of Oral Administration of NE-58095NF Tablets Versus Once-daily Oral Administration of NE-58095 2.5-mg Tablets for the Treatment of Involutional Osteoporosis.
NE-58095; NE-58095NF

Bone Alteration [PE] Clinical Trial using Low Magnitude Mechanical Stimulation; Sham Low Magnitude Mechanical Stimulation

University of Pennsylvania - Recruiting 45 years to 65 years.
- Osteoporosis Treatment Response Assessed by Micromechanical Modeling of MRI Data.
Low Magnitude Mechanical Stimulation; Sham Low Magnitude Mechanical Stimulation

Compression Fracture of Vertebral Body, Osteoporosis, or Cancer Clinical Trial using Balloon kyphoplasty

Medtronic Spinal and Biologics - Recruiting 65 years or older.
- A Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures.
Balloon kyphoplasty

Osteoarthritis of the Knee Clinical Trial using X0002; Placebo

Techfields Pharma Co. Ltd - Recruiting 35 years to 85 years.
- A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis.
X0002; Placebo

Osteoporosis Clinical Trial using Odanacatib; Placebo

Merck Sharp & Dohme Corp. - Recruiting 12 years to 25 years.
- A Single-Dose Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Odanacatib in Adolescents and Young Adults Treated With Glucocorticoids.
Odanacatib; Placebo

Postmenopausal Osteoporosis Clinical Trial using Romosozumab; Placebo

Amgen - Recruiting 55 years to 90 years.
- A Multicenter, Randomized, Multiple-dose Phase 3 Study to Evaluate 2 Different Formulations of Romosozumab in Postmenopausal Women With Osteoporosis.
Romosozumab; Placebo

Osteoporosis, or Atypical Femoral Fracture Clinical Trial using teriparatide

University of Pittsburgh - Recruiting N/A or older.
- Fracture (FX) Improvement With Teriparatide: FiX-IT Study.
teriparatide

Severe Osteoporosis Clinical Trial using PREOBr Intravenous Infusion

Erasme University Hospital - Recruiting 40 years to 85 years.
- Treatment of Severe Osteoporosis by Intravenous Infusion of Pre-osteoblastic Cells - An Open Pilot Study.
PREOBr Intravenous Infusion

Systemic Lupus Erythematosus (SLE) Clinical Trial using Acthar; Placebo for Acthar

Questcor Pharmaceuticals, Inc. - Recruiting 18 years or older.
- A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease.
Acthar; Placebo for Acthar

Osteoporosis, With or Without Treatment, Bisphosphonate Treatment Clinical Trial

University of Pennsylvania - Recruiting 18 years or older.
- Biomarker Identification in Orthopaedic and Oral Maxillofacial Subjects.

Osteoporosis, Postmenopausal Clinical Trial using E2 transdermal (Julina, BAY86-5435)

Bayer - Recruiting N/A or older.
- Drug Use Investigation of Julina Tablets 0.5 mg (Postmenopausal Osteoporosis).
E2 transdermal (Julina, BAY86-5435)

Rheumatoid Arthritis Clinical Trial using GLPG0634; Placebo

Galapagos NV - Recruiting 18 years or older.
- Randomized, Double-blind, Placebo-controlled, Multicenter, Phase IIb Dose Finding Study of GLPG0634 Administered for 24 Weeks as Monotherapy to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate (MTX) Alone.
GLPG0634; Placebo

Osteoporosis, or Fracture Clinical Trial

National Taiwan University Hospital - Recruiting 18 years to 90 years.
- to Compare the Efficacy of Parameters From Different Imaging Modality in Predicting the Risk of Future Vertebral Compression Fracture in Osteoporotic Patients..

Postmenopausal Osteoporosis Clinical Trial using Teriparatide; Risedronate; Placebo; Calcium; Vitamin D

Eli Lilly and Company - Recruiting 45 years or older.
- Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures.
Teriparatide; Risedronate; Placebo; Calcium; Vitamin D

Osteoporosis Clinical Trial using Teriparatide; Risedronate; Placebo; Calcium; Vitamin D

Eli Lilly and Company - Recruiting 50 years or older.
- Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture.
Teriparatide; Risedronate; Placebo; Calcium; Vitamin D

Osteopenia, or Osteoporosis Clinical Trial using BPS804; Placebo

Novartis - Recruiting 45 years to 85 years.
- A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Postmenopausal Women With Low Bone Mineral Density.
BPS804; Placebo

Post Menopausal Osteoporosis Clinical Trial using Denosumab; Zoledronic Acid

Amgen - Recruiting 55 years or older.
- A Randomized Double-blind Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.
Denosumab; Zoledronic Acid

Osteoporosis, Postmenopausal Clinical Trial using Denosumab; Placebo

GlaxoSmithKline - Recruiting 60 years to 90 years.
- A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Chinese Postmenopausal Women With Osteoporosis at Increased Risk of Fracture.
Denosumab; Placebo

Postmenopausal, Osteopenia, Rheumatoid Arthritis, or Osteoporosis Clinical Trial using Etanercept; Denosumab

Amgen - Recruiting 45 years to 80 years.
- The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis.
Etanercept; Denosumab

Menopause, Hot Flushes, Osteoporosis, or Dyslipidemia Clinical Trial using Placebo; Red Clover extract

Aarhus University Hospital - Recruiting 45 years to 65 years.
- Alternative Treatments for Menopausal Women: The Efficacy of a Novel Red Clover Treatment on Menopausal Women..
Placebo; Red Clover extract

Osteoporosis, Postmenopausal Clinical Trial using E2/LNG oral (Wellnara, BAY86-5029)

Bayer - Recruiting N/A or older.
- Drug Use Investigation of Wellnara Tablet.
E2/LNG oral (Wellnara, BAY86-5029)

Osteogenesis Imperfecta Clinical Trial using Zoledronic acid; Teriparatide; placebo zoledronic acid; placebo teriparatide

University of Aarhus - Recruiting 22 years to 70 years.
- The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta.
Zoledronic acid; Teriparatide; placebo zoledronic acid; placebo teriparatide

Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporo Clinical Trial using Denosumab; Placebo

Amgen - Recruiting 30 years or older.
- A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy.
Denosumab; Placebo

Osteoporosis Clinical Trial

National Taiwan University Hospital - Recruiting 40 years to 90 years.
- Osteoporosis and Fall Prevention Education With High Risk Population Telephone Follow up Study.

Fatty Liver Clinical Trial using Resveratrol; Placebo

University of Aarhus - Recruiting 18 years to 70 years.
- Long-term Investigation of Resveratrol on Management of Metabolic Syndrome, Osteoporosis and Inflammation, and Identification of Plant Derived Anti-inflammatory Compounds, Study 3.
Resveratrol; Placebo

Atypical Femur Fracture, Atypical Subtrochanteric Fracture, or Os Clinical Trial

University Health Network, Toronto - Recruiting 20 years or older.
- Atypical Femur Fracture Ontario Cohort Registry.

Osteoporosis Clinical Trial using Melatonin

University of Aarhus - Recruiting 55 years to 75 years.
- Treatment of Osteopenia With Melatonin: Effects on BMD, Muscle Strength and Quality of Life.
Melatonin

Diseases of the Musculo-skeletal System and Connective Tissue, or Clinical Trial using Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger)

Ministry of Health & Welfare, Korea - Recruiting 50 years or older.
- A Randomized, Single Center, Double Blind, Parallel, Placebo-controlled Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis.
Granules, Chung A Won 3g (Eucommiaceae, Psoralea corylifolia, Walnut, Ginger)

Osteoporosis Clinical Trial using Calcitriol; Alfacalcidol; Cholecalciferol; Placebo

Seoul National University Hospital - Recruiting 20 years to 40 years.
- Comparisons of the Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels.
Calcitriol; Alfacalcidol; Cholecalciferol; Placebo

Osteoporosis Clinical Trial

National Taiwan University Hospital - Recruiting 65 years to 85 years.
- Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis.

Osteoporosis, or Obstructive Lung Disease Clinical Trial

University of British Columbia - Recruiting 65 years or older.
- A Prospective Baseline Assessment of the Risk of Osteoporosis in Patients With Chronic Obstructive Lung Disease and Outcomes After 2 Years; a Pilot Study.

Prostate Cancer Clinical Trial

Toowoomba Regional Cancer Research Centre - Recruiting N/A or older.
- A Phase 2 Clinical Trial Exploring 3-Dimensional Imaging of Androgen Deprivation Induced Osteoporosis, Radiotherapy Hypofractionation and the Prognostic Significance of Micrometastatic Disease in Men With Prostate Cancer.

Bone Diseases, Metabolic, or Osteoporosis, Postmenopausal Clinical Trial using potassium citrate

Weill Medical College of Cornell University - Recruiting 45 years to 75 years.
- A Randomized Placebo Controlled Double Blind Investigation of the Effects of Potassium Citrate on Bone Metabolism in Postmenopausal Osteopenia.
potassium citrate

Osteoporosis Clinical Trial

Odense University Hospital - Recruiting 60 years to 70 years.
- Study on Male Osteoporosis and Aging.

Osteoporosis Clinical Trial using Alendronate

McGill University Health Center - Recruiting 55 years or older.
- A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture..
Alendronate